Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,944 | 15 | 49.3% |
| Food and Beverage | $23,748 | 1,104 | 33.5% |
| Consulting Fee | $6,755 | 6 | 9.5% |
| Travel and Lodging | $5,240 | 16 | 7.4% |
| Education | $254.43 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $51,925 | 322 | $0 (2020) |
| Abbott Laboratories | $6,031 | 191 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,753 | 97 | $0 (2024) |
| ABBVIE INC. | $1,482 | 13 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,470 | 79 | $0 (2024) |
| US WorldMeds, LLC | $770.60 | 63 | $0 (2020) |
| Lundbeck LLC | $744.40 | 38 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $730.75 | 35 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $667.91 | 36 | $0 (2023) |
| GE HealthCare | $535.35 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,729 | 76 | Abbott Laboratories ($2,500) |
| 2023 | $3,985 | 112 | Abbott Laboratories ($1,538) |
| 2022 | $2,157 | 122 | Abbott Laboratories ($912.42) |
| 2021 | $2,102 | 127 | Abbott Laboratories ($304.48) |
| 2020 | $2,774 | 139 | Medtronic USA, Inc. ($951.30) |
| 2019 | $14,741 | 194 | Medtronic USA, Inc. ($12,988) |
| 2018 | $32,346 | 224 | Medtronic USA, Inc. ($30,482) |
| 2017 | $9,108 | 152 | Medtronic USA, Inc. ($7,504) |
All Payment Transactions
1,146 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $39.76 | General |
| Category: Neuromodulation | ||||||
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: Neuromodulation | ||||||
| 12/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: Musculoskeletal | ||||||
| 11/20/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neurology | ||||||
| 11/11/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: AMANTADINE | ||||||
| 11/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Neurology | ||||||
| 10/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Central Nervous System | ||||||
| 10/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/15/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $30.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Central Nervous System | ||||||
| 10/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Central Nervous System | ||||||
| 09/30/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Neurology | ||||||
| 09/24/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $141.09 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/14/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Neuromodulation | ||||||
| 09/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: Central Nervous System | ||||||
| 09/05/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: Neurology | ||||||
| 08/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.04 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Adenosine A2A Receptors | ||||||
| 08/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Central Nervous System | ||||||
| 08/21/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $120.13 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,238 | 13,125 | $1.4M | $483,677 |
| 2022 | 24 | 1,494 | 16,780 | $1.7M | $593,886 |
| 2021 | 23 | 1,570 | 18,224 | $1.9M | $649,914 |
| 2020 | 27 | 2,131 | 14,671 | $1.8M | $643,407 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 50 minutes | Office | 2021 | 130 | 133 | $85,870 | $29,727 | 34.6% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2021 | 13 | 1,850 | $49,821 | $17,625 | 35.4% |
| J0475 | Injection, baclofen, 10 mg | Office | 2021 | 13 | 110 | $42,764 | $15,631 | 36.6% |
| 99354 | Prolonged outpatient service, first hour | Office | 2021 | 122 | 125 | $36,338 | $12,916 | 35.5% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 82 | 298 | $34,443 | $12,045 | 35.0% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 41 | 106 | $32,467 | $11,927 | 36.7% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Office | 2021 | 23 | 65 | $20,314 | $10,231 | 50.4% |
| 96112 | Developmental test administration by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 78 | 82 | $24,262 | $8,678 | 35.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $24,781 | $7,852 | 31.7% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 48 | 100 | $19,991 | $7,151 | 35.8% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Office | 2021 | 19 | 41 | $16,660 | $5,363 | 32.2% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2021 | 29 | 62 | $13,191 | $4,718 | 35.8% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Office | 2021 | 32 | 67 | $22,958 | $4,476 | 19.5% |
| 64611 | Injection of chemical for destruction of salivary glands on both sides of the mouth | Office | 2021 | 16 | 38 | $11,013 | $3,214 | 29.2% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2021 | 13 | 24 | $5,588 | $1,999 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 22 | $6,412 | $1,919 | 29.9% |
| 99358 | Prolonged patient service without direct patient contact first hour | Office | 2021 | 19 | 20 | $5,004 | $1,700 | 34.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 14 | $4,178 | $1,484 | 35.5% |
| P9041 | Infusion, albumin (human), 5%, 50 ml | Office | 2021 | 61 | 145 | $3,422 | $1,219 | 35.6% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 316 | 1,671 | $484,151 | $170,592 | 35.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 299 | 1,429 | $347,749 | $123,606 | 35.5% |
| 95984 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, additional 15 minutes face-to-face time with qualified health care professional | Office | 2020 | 95 | 1,780 | $183,118 | $65,501 | 35.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 231 | 517 | $159,509 | $51,872 | 32.5% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2020 | 70 | 6,953 | $119,062 | $44,168 | 37.1% |
| J0475 | Injection, baclofen, 10 mg | Office | 2020 | 16 | 249 | $96,572 | $33,717 | 34.9% |
About Dr. Robert Izor, MD
Dr. Robert Izor, MD is a Neurology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164409108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Izor, MD has received a total of $70,941 in payments from pharmaceutical and medical device companies, with $3,729 received in 2024. These payments were reported across 1,146 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,944).
As a Medicare-enrolled provider, Izor has provided services to 6,433 Medicare beneficiaries, totaling 62,800 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Austin, TX
- Active Since 12/30/2005
- Last Updated 07/21/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164409108
Products in Payments
- ACTIVA (Device) $47,105
- INFINITY (Device) $4,950
- INVISX (Device) $3,968
- NUPLAZID (Drug) $1,753
- Infinity DBS Pulse Generators (Device) $875.48
- AUSTEDO (Drug) $866.34
- NORTHERA (Drug) $690.46
- RECLAIM (Device) $690.00
- INGREZZA (Drug) $541.09
- Dysport (Drug) $483.69
- GOCOVRI (Drug) $478.35
- Neupro (Drug) $446.76
- Xadago (Drug) $367.45
- INBRIJA (Drug) $367.18
- NOURIANZ (Drug) $344.67
- Austedo XR (Drug) $332.86
- APOKYN (Drug) $270.99
- NUEDEXTA (Drug) $255.16
- BOTOX (Biological) $246.75
- RYTARY (Drug) $238.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Austin
Dr. Elliot Frohman, Md Phd, MD PHD
Neurology — Payments: $633,909
Dr. David Morledge, M.d, M.D
Neurology — Payments: $180,453
Dr. Sami Aboumatar, M.d, M.D
Neurology — Payments: $159,184
Dr. Subhashie Wijemanne, M.d, M.D
Neurology — Payments: $140,816
Dr. Krishna Pokala, Md, MD
Neurology — Payments: $103,512
Dr. Rajat Gupta, M.d, M.D
Neurology — Payments: $91,931